ArticleInvestigational new drugs2010

Triphenyltin(IV) 2-[(E)-2-(aryl)-1-diazenyl]benzoates as anticancer drugs: synthesis, structural characterization, in vitro cytotoxicity and study of its influence towards the mechanistic role of some key enzymes.

Tushar S Basu Baul et al.PubMed ↗Publisher ↗

No numbers read from the abstract.